Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: A randomized, controlled, double-blind trial

Autor: Philippe de Saussure, Gaëlle Ory, Jean-Louis Frossard, Beat Burckhardt, Antoine Hadengue, Berj Armenian, Raymond de Peyer, Laurent Spahr, Pierre Edouard Queneau, Emiliano Giostra

Publikováno v: Gastroenterology. 123:17-23

Background & Aims: Emergency endoscopy may be difficult in upper gastrointestinal bleeding when blood obscures the visibility. Erythromycin, a motilin agonist, induces gastric emptying. We investigated whether an intravenous bolus infusion of erythro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0cc42f5657ca2b45995b5d1b0fa5c07c
https://doi.org/10.1053/gast.2002.34230

Treatment of arteriovenous malformation of the pancreas: a case report

Autor: Pierre-Edouard Queneau, Mustapha Adham, Frank Pilleul, Rodica Gincul, Thierry Ponchon, Jérôme Dumortier, Mihai Ciocirlan

Publikováno v: European Journal of Gastroenterology and Hepatology
European Journal of Gastroenterology and Hepatology, Lippincott, Williams & Wilkins, 2010, 22 (1), pp.116--120

Pancreatic arteriovenous malformation (AVM) is a rare disease, generally asymptomatic, but sometimes complicated by gastrointestinal bleeding or pancreatitis. We report a case of a 55-year-old man presenting with a large pancreatic AVM. The diagnosis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42ba40375010b77964db66b7500f76ca
https://pubmed.ncbi.nlm.nih.gov/19687743

Ischemic colitis during pregnancy and contraceptive medication

Autor: Laurent Spahr, Berj Armenian, Marie-Anne Brundler, Jean-Louis Frossard, Antoine Hadengue, Pierre Edouard Queneau

Publikováno v: Digestion. 64(2)

Ischemic bowel disease is generally considered a disease of the elderly and usually consists of reversible colopathy. Nonocclusive causes of ischemic colitis include low-flow states due to cardiac dysfunction and hypovolemia and use of certain medica

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecc52a30b69f0b7d17376763d63d7b7c
https://pubmed.ncbi.nlm.nih.gov/11684827

Treatment of mild chronic hepatitis C with interferon alpha-2b: results of a multi-centre randomized study in 80 patients

Autor: Florence Osaer, Serge Fratte, Dominique Bettinger, Jean-Pierre Carbillet, Pierre-Edouard Queneau, Anne Minello-Franza, Jean-Philippe Miguet, Solange Bresson-Hadni, Benedicte Monnot, J.-J. Raabe, Gérard Thiéfin, Jean-Pierre Bronowicki

Publikováno v: European journal of gastroenterologyhepatology. 13(2)

OBJECTIVE The natural history of mild chronic hepatitis C is not well-known and the benefit of treating this form of the disease is not well-defined. We conducted a pilot study to answer this question. DESIGN Mild chronic hepatitis C was defined by p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a097527ae0bf60b639cf90f7ffc2ee02
https://pubmed.ncbi.nlm.nih.gov/11246613

Improvement of cyclosporin A-induced cholestasis by tauroursodeoxycholate in a long-term study in the rat

Autor: M Guitaoui, J.C. Montet, E Mesdjian, Alain Durand, Pierre-Edouard Queneau, Bertault-Perès P

Publikováno v: Digestive diseases and sciences. 39(7)

Cyclosporin A is an essential immunosuppressive drug, but it is potentially toxic to the kidney and liver. Ursodeoxycholic acid, a hydrophilic bile acid, has been reported to improve cholestasis in liver disease in man. The purpose of this work was t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::398d5a13ea9d7b789a0b2f7505b4daf5
https://pubmed.ncbi.nlm.nih.gov/8026273